SERPINE1 and osteosarcoma: Further study found that plasminogen activator inhibitor-1 (PAI-1) was the downstream of miR-34a, and suppressing PAI-1 could inhibit osteosarcoma dedifferentiation into cancer stem-like cells by blocking Sox2 expression [117].